X4 PHARMACEUTICALS, INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
X4 PHARMACEUTICALS, INC (XFOR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 767.28 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 682.63K shares, a 1639.14% increase year-over-year.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 84.65K shares, a 4.77% increase year-over-year.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 907.53K shares, a 118.50% increase year-over-year.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 79.01K shares, a 59.38% decline year-over-year.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 1.11M shares, a 1.90% increase from fiscal 2024.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 1.09M shares.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 228.56K shares, a 32.91% decline from fiscal 2021.
- X4 PHARMACEUTICALS, INC share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 340.65K shares, a 26.43% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 682.63K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 767.28K shares 10-Q · filed 2026-08-06 | 1.67M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.75M shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 84.65K shares 10-Q · filed 2026-05-06 | 992.18K shares derived: sum of 2 quarters · filed 2026-05-06 | 1.07M shares derived: sum of 3 quarters · filed 2026-05-06 | 1.11M shares derived: sum of 4 quarters · filed 2026-05-06 | |
| 2025-12-31 | 907.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | 986.53K shares derived: sum of 2 quarters · filed 2026-03-17 | 1.03M shares derived: sum of 3 quarters · filed 2026-03-17 | 1.11M shares 10-K · filed 2026-03-17 | |
| 2025-09-30 | 79.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 118.26K shares derived: sum of 2 quarters · filed 2025-11-05 | 199.06K shares 10-Q · filed 2025-11-05 | 614.39K shares derived: sum of 4 quarters · filed 2025-11-05 | |
| 2025-06-30 | 39.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | 120.05K shares 10-Q · filed 2025-08-08 | 535.39K shares derived: sum of 3 quarters · filed 2025-08-08 | 729.91K shares derived: sum of 4 quarters · filed 2025-08-08 | |
| 2025-03-31 | 80.80K shares 10-Q · filed 2025-05-01 | 496.14K shares derived: sum of 2 quarters · filed 2025-05-01 | 690.66K shares derived: sum of 3 quarters · filed 2025-05-01 | 853.61K shares derived: sum of 4 quarters · filed 2025-05-01 | |
| 2024-12-31 | 415.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | 609.86K shares derived: sum of 2 quarters · filed 2025-03-26 | 772.81K shares derived: sum of 3 quarters · filed 2025-03-26 | 1.09M shares 10-K · filed 2025-03-26 | |
| 2024-09-30 | 194.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 357.47K shares derived: sum of 2 quarters · filed 2024-11-13 | 670.64K shares 10-Q · filed 2024-11-13 | ||
| 2024-06-30 | 162.95K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 476.12K shares 10-Q · filed 2024-08-08 | |||
| 2024-03-31 | 313.17K shares 10-Q · filed 2024-05-07 | ||||
| 2023-09-30 | 65.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 73.28K shares derived: sum of 2 quarters · filed 2023-11-09 | 99.36K shares 10-Q · filed 2023-11-09 | -84.41K shares derived: sum of 4 quarters · filed 2024-03-21 | |
| 2023-06-30 | 7.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 33.66K shares 10-Q · filed 2023-08-10 | -150.11K shares derived: sum of 3 quarters · filed 2024-03-21 | 25.27K shares derived: sum of 4 quarters · filed 2024-03-21 | |
| 2023-03-31 | 26.08K shares 10-Q · filed 2023-05-04 | -157.69K shares derived: sum of 2 quarters · filed 2024-03-21 | 17.69K shares derived: sum of 3 quarters · filed 2024-03-21 | 154.90K shares derived: sum of 4 quarters · filed 2024-03-21 | |
| 2022-12-31 | -183.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -8.39K shares derived: sum of 2 quarters · filed 2024-03-21 | 128.81K shares derived: sum of 3 quarters · filed 2024-03-21 | 228.56K shares 10-K · filed 2024-03-21 | 653.77K shares 10-K · filed 2023-03-21 |
| 2022-09-30 | 175.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 312.58K shares derived: sum of 2 quarters · filed 2022-11-03 | 412.33K shares 10-Q · filed 2022-11-03 | 500.47K shares derived: sum of 4 quarters · filed 2022-11-03 | |
| 2022-06-30 | 137.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 236.95K shares 10-Q · filed 2022-08-04 | 325.09K shares derived: sum of 3 quarters · filed 2022-08-04 | 365.92K shares derived: sum of 4 quarters · filed 2022-08-04 | |
| 2022-03-31 | 99.74K shares 10-Q · filed 2022-05-12 | 187.88K shares derived: sum of 2 quarters · filed 2022-05-12 | 228.72K shares derived: sum of 3 quarters · filed 2022-05-12 | 332.92K shares derived: sum of 4 quarters · filed 2022-05-12 | |
| 2021-12-31 | 88.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 128.97K shares derived: sum of 2 quarters · filed 2022-03-17 | 233.18K shares derived: sum of 3 quarters · filed 2022-03-17 | 340.65K shares 10-K · filed 2022-03-17 | |
| 2021-09-30 | 40.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 145.04K shares derived: sum of 2 quarters · filed 2021-11-04 | 252.51K shares 10-Q · filed 2021-11-04 | 356.98K shares derived: sum of 4 quarters · filed 2021-11-04 | |
| 2021-06-30 | 104.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 211.68K shares 10-Q · filed 2021-08-03 | 316.14K shares derived: sum of 3 quarters · filed 2021-08-03 | 345.42K shares derived: sum of 4 quarters · filed 2021-08-03 | |
| 2021-03-31 | 107.47K shares 10-Q · filed 2021-05-06 | 211.94K shares derived: sum of 2 quarters · filed 2021-05-06 | 241.21K shares derived: sum of 3 quarters · filed 2021-05-06 | 354.32K shares derived: sum of 4 quarters · filed 2021-05-06 | |
| 2020-12-31 | 104.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | 133.74K shares derived: sum of 2 quarters · filed 2021-03-19 | 246.85K shares derived: sum of 3 quarters · filed 2021-03-19 | 269.44K shares 10-K · filed 2021-03-19 | |
| 2020-09-30 | 29.27K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 142.38K shares derived: sum of 2 quarters · filed 2020-11-05 | 164.98K shares 10-Q · filed 2020-11-05 | 220.55K shares derived: sum of 4 quarters · filed 2020-11-05 | |
| 2020-06-30 | 113.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 135.71K shares 10-Q · filed 2020-08-04 | 191.28K shares derived: sum of 3 quarters · filed 2020-08-04 | 288.98K shares derived: sum of 4 quarters · filed 2020-08-04 | |
| 2020-03-31 | 22.59K shares 10-Q · filed 2020-05-07 | 78.17K shares derived: sum of 2 quarters · filed 2020-05-07 | 175.87K shares derived: sum of 3 quarters · filed 2020-05-07 | 309.84K shares derived: sum of 4 quarters · filed 2020-05-07 | |
| 2019-12-31 | 55.57K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | 153.27K shares derived: sum of 2 quarters · filed 2020-03-12 | 287.25K shares derived: sum of 3 quarters · filed 2020-03-12 | 309.63K shares 10-K · filed 2020-03-12 | |
| 2019-09-30 | 97.70K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 231.68K shares derived: sum of 2 quarters · filed 2019-11-07 | 254.05K shares 10-Q · filed 2019-11-07 | 352.67K shares derived: sum of 4 quarters · filed 2019-11-07 | |
| 2019-06-30 | 133.97K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 156.35K shares 10-Q · filed 2019-08-07 | 254.97K shares derived: sum of 3 quarters · filed 2019-08-07 | 306.38K shares derived: sum of 4 quarters · filed 2019-08-07 | |
| 2019-03-31 | 22.38K shares 10-Q · filed 2019-05-15 | 121.00K shares derived: sum of 2 quarters · filed 2019-05-15 | 172.40K shares derived: sum of 3 quarters · filed 2019-05-15 | ||
| 2018-12-31 | 98.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | 150.03K shares derived: sum of 2 quarters · filed 2019-03-11 | 262.00K shares 10-K · filed 2019-03-11 | ||
| 2018-09-30 | 51.41K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 163.38K shares 10-Q · filed 2018-11-09 | |||
| 2018-06-30 | 111.98K shares 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |